Crude oil prices fell to weigh the markets down to a lower close with the Dow falling 55 points to 17,737. Nasdaq dropped 22 points to 4,891.
On the upside
Shares of Galena Biopharma (Nasdaq: GALE) climbed again.
ACR Communications noted that Genocea Biosciences (Nasdaq: GNCA) reported positive Phase 2 results last week for GEN-003 to treat genital herpes.
Daily Stock Reporter added California Resources (NYSE: CRC) to its watch list.
On the downside
Clovis Oncology (Nasdaq: CLVS) chief financial officer Erie T. Mast resigned and the company appointed Daniel W. Muehl to the position of principal financial officer and principal accounting officer.
Profit taking weighed down shares of Petrobras (NYSE: PBR).
Shares of Gold Fields (NYSE: GFI) fell as gold prices slipped.
In the broad market, declining issues outpaced advancers by a margin of more than 5 to 2 on the NYSE and by more than 8 to 5 on Nasdaq. The broader S&P 500 lost 6 points to 2,066. Bitcoin added a fraction to $417.
